When we examined a shorter observation window (8 weeks before and after initiation), results were consistent, with a point estimate even suggesting a 15% reduction in psychotic events shortly after treatment start, though this did not reach statistical significance (RR 0.85, 95% CI 0.68–1.05; see Supplementary Figure S1 ).
← all excerpts
Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study.
1
—
—